Dutch Diversified Financial Stock News

ENXTAM:DSFIR
ENXTAM:DSFIRChemicals

A Look At DSM-Firmenich (ENXTAM:DSFIR) Valuation After A €540 Million Share Buyback Announcement

Buyback announcement and what it could mean for DSM-Firmenich shares DSM-Firmenich (ENXTAM:DSFIR) has announced a share repurchase program of up to €540 million. Of this amount, €500 million is aimed at reducing issued capital and €40 million is reserved for share-based compensation commitments. See our latest analysis for DSM-Firmenich. At a share price of €58.12, DSM-Firmenich’s recent buyback announcement lands after a softer run, with a 30-day share price return of a 4% decline and a...
ENXTAM:AMG
ENXTAM:AMGMetals and Mining

Assessing AMG Critical Materials (ENXTAM:AMG) Valuation After Recent Share Price Pullback

AMG Critical Materials at a Glance After Recent Share Moves AMG Critical Materials (ENXTAM:AMG) has drawn fresh attention after a recent share price pullback, with the stock down about 11% over the past month but still showing a strong 1 year total return. See our latest analysis for AMG Critical Materials. The recent 11% monthly share price pullback, alongside a 5.6% one day share price decline and 8.9% seven day share price decline, contrasts with a strong 90.96% one year total shareholder...
ENXTAM:AVTX
ENXTAM:AVTXProfessional Services

Avantium (ENXTAM:AVTX) Loss Narrows In H1 2025 Reinforcing Debate On Persistent Unprofitability

Avantium (ENXTAM:AVTX) has posted another loss for H1 2025, with revenue of €6.7 million, basic EPS of €1.08 loss, and net income loss of €9.4 million framing the latest set of numbers. Over recent halves the company has seen revenue move from €9.0 million in H1 2024 to €12.1 million in H2 2024, and EPS shift from a €1.75 loss in H1 2024 to a €1.69 loss in H2 2024, while trailing twelve month EPS sits at a €2.86 loss on €18.8 million of revenue. For investors, the key question now is whether...
ENXTAM:OCI
ENXTAM:OCIChemicals

OCI (ENXTAM:OCI) Heavy EPS Loss In 1H 2025 Reinforces Bearish Margin Concerns

OCI (ENXTAM:OCI) FY 2025 earnings snapshot OCI (ENXTAM:OCI) has opened FY 2025 with a mixed first half, reporting total revenue of US$566.9 million and a basic EPS loss of US$1.57, alongside earnings from discontinued operations of US$673.6 million and net income loss excluding extra items of US$330.6 million, against a share price of €3.48. Over recent periods the company has seen revenue move from US$509 million in 1H 2024 to US$566.9 million in 1H 2025. Basic EPS shifted from a loss of...
ENXTAM:CVC
ENXTAM:CVCCapital Markets

Is It Time To Reassess CVC Capital Partners (ENXTAM:CVC) After A 38% Share Price Slide?

This article looks at whether CVC Capital Partners shares might be starting to look like value after a difficult period, by exploring what the current price could be implying about the company. The stock last closed at €11.32, with returns of a 4.5% decline over 7 days, an 11.8% decline over 30 days, a 19.3% decline year to date, and a 38.5% decline over the past year, which may have influenced how investors view both its potential and its risks. Recent coverage has examined how CVC Capital...
ENXTAM:AGN
ENXTAM:AGNInsurance

A Look At Aegon (ENXTAM:AGN) Valuation After New China Insurance Asset Management Expansion

China expansion puts Aegon in focus Aegon (ENXTAM:AGN) is back on investors’ radar after launching Aegon Insurance Asset Management Company in Shanghai, a wholly owned unit that gives it direct access to long-term investments in China. The new license lets Aegon target areas such as infrastructure and renewable energy within China’s regulated insurance asset management market. This development could influence how investors think about the group’s future capital deployment and risk...
ENXTAM:AALB
ENXTAM:AALBMachinery

Assessing Aalberts (ENXTAM:AALB) Valuation After Recent Share Price Weakness

How Aalberts Stock Has Been Performing Recently Aalberts (ENXTAM:AALB) has moved lower in the very short term, with a 1 day decline of about 1% and a 7 day decline of about 1.4%, drawing fresh attention from investors. Over the past month the share price shows a decline of about 10%. Over the past 3 months it shows a gain of roughly 11%, offering a mixed picture for recent traders and for longer holding periods. See our latest analysis for Aalberts. With the share price at €31.42, Aalberts...
ENXTAM:KPN
ENXTAM:KPNTelecom

Does Twilio–Google RCS Partnership Make KPN the Backbone of Dutch Business Messaging (ENXTAM:KPN)?

At Mobile World Congress in March 2026, Twilio announced a partnership with KPN Netherlands and Google to roll out nationwide Rich Communication Services (RCS) Business Messaging across all major Dutch mobile operators, with Android support at launch and broader device coverage expected in 2026. This collaboration places KPN at the core of the Netherlands’ business messaging infrastructure, enabling enterprises to use richer, measurable and verified communications within native messaging...
ENXTAM:HEIA
ENXTAM:HEIABeverage

Is Legal Setbacks And Zero-Calorie 0.0 Ultimate Altering The Investment Case For Heineken (ENXTAM:HEIA)?

In February 2026, the Amsterdam District Court issued an interim judgment in Macedonian Thrace Brewery’s long-running damages case against Heineken and Athenian Brewery, accepting MTB’s expert model and indicating principal damages of at least €43.00 million, with total awards including interest expected to exceed €83.00 million once finalized. Around the same time, Heineken advanced its push into non-alcoholic beer with the launch of Heineken 0.0 Ultimate in select U.S. states, introducing...
ENXTAM:PRX
ENXTAM:PRXMultiline Retail

Prosus (ENXTAM:PRX) Valuation Check After Tencent-Led Share Price Rebound On Iran De‑Escalation Hopes

Prosus (ENXTAM:PRX) jumped in early European trading after a sharp move higher in Tencent Holdings, as investors reacted to a U.S. presidential statement that hinted at possible easing of tensions in the Iran conflict. See our latest analysis for Prosus. Beyond today’s reaction to Tencent, Prosus has a 7.6% 1 year total shareholder return and a 57.8% 3 year total shareholder return, despite a 13.4% year to date share price decline. This suggests recent momentum has been rebuilding after a...
ENXTAM:AALB
ENXTAM:AALBMachinery

Is Aalberts (ENXTAM:AALB) Share Price Weakness Creating A Long Term Opportunity?

If you are wondering whether Aalberts is fairly priced or offering value at its recent share price, this article will walk through what the numbers actually say rather than relying on headlines or hype. The stock last closed at €31.76, with a 7 day return of a 4.5% decline, a 30 day return of a 9.8% decline, a year to date return of 11.4%, and a 1 year return of a 2.5% decline. Taken together, this gives you a mixed picture of recent momentum and shifting risk appetite. Recent coverage has...
ENXTAM:WHA
ENXTAM:WHARetail REITs

Wereldhave (ENXTAM:WHA) Valuation Check After Strong Multi Year Shareholder Returns

How Wereldhave’s recent share performance frames the current valuation debate Wereldhave (ENXTAM:WHA) has drawn attention after a year total return of 45.7%, alongside a past 3 months gain of 12.1%, even as the share price has seen a 3% decline over the past month. For investors tracking consistency rather than short term price moves, the 3 year total return of 89.3% and 5 year total return of 105.1% sit against current annual revenue of €215.859m and net income of €73.344m. See our latest...
ENXTAM:ASML
ENXTAM:ASMLSemiconductor

The Bull Case For ASML Holding (ENXTAM:ASML) Could Change Following Its Hybrid Bonding And Packaging Pivot

In recent months, ASML Holding has reinforced its EUV lithography leadership, secured continued reliance from major chipmakers, reported record bookings, and outlined new leadership appointments and capital return plans following its 2025 performance. At the same time, ASML is moving into advanced packaging and hybrid bonding tools while Chinese efforts to build rival EUV capabilities face substantial technological and supply chain hurdles. Now we will examine how ASML’s push into hybrid...
ENXTAM:PHIA
ENXTAM:PHIAMedical Equipment

Assessing Philips (ENXTAM:PHIA) Valuation After Recent Share Price Pullback

Recent performance snapshot Without a specific headline event driving attention today, Koninklijke Philips (ENXTAM:PHIA) may still interest you if you are tracking healthcare names with mixed short term and longer term return profiles. The stock shows a 0.9% decline over the past day and a 2.0% decline over the past week, with a larger 8.4% drop over the past month, while the past 3 months reflect a 7.3% gain. See our latest analysis for Koninklijke Philips. At a share price of €24.41, the...
ENXTAM:CVC
ENXTAM:CVCCapital Markets

A Look At CVC Capital Partners (ENXTAM:CVC) Valuation After 2025 Results And Performance Fee Guidance Reset

CVC Capital Partners (ENXTAM:CVC) is back in focus after its 2025 earnings release, where record realisations and profit met a sharp reset in performance fee guidance that weighed on investor sentiment. See our latest analysis for CVC Capital Partners. The share price reaction around the 2025 results sits within a tougher year overall, with a 90 day share price return of 21.89% and a 1 year total shareholder return decline of 40.23%, suggesting momentum has been fading despite ongoing...
ENXTAM:SIFG
ENXTAM:SIFGElectrical

Sif Holding (ENXTAM:SIFG) Loss Worsens To €25.9 Million Challenging Bullish Turnaround Narratives

Sif Holding (ENXTAM:SIFG) has put fresh numbers on the table for FY 2025, with first half revenue of €258.2 million and a basic EPS loss of €0.91, setting a clear tone for where profitability currently stands. The company has seen revenue move from €230.98 million and EPS of €0.21 in the first half of 2024 to €198.0 million and an EPS loss of €0.36 in the second half of 2024, before landing at the latest half-year print. This keeps the focus firmly on how margins are holding up through this...
ENXTAM:DSFIR
ENXTAM:DSFIRChemicals

Assessing DSM-Firmenich (ENXTAM:DSFIR) After A 37% One-Year Share Price Slide

If you are wondering whether DSM-Firmenich at around €59 still reflects its true worth, you are not alone, and this article is built to help you assess what that price might really represent. The stock has been through a rough patch, with the share price down 14.6% over the last 30 days and 37.4% over the past year. It is up 2.9% over the past week and down 14.3% year to date. Recent coverage around DSM-Firmenich has focused on its position in the broader materials and specialty ingredients...
ENXTAM:ARCAD
ENXTAM:ARCADProfessional Services

Assessing Arcadis (ENXTAM:ARCAD) Valuation After New Los Angeles Infrastructure Contracts

Event overview and why it matters Arcadis (ENXTAM:ARCAD) has secured two new contracts with the City of Los Angeles, covering work on the Los Angeles Convention Center Modernization and Expansion and the Department of Public Works Bureau of Engineering's Clean Water Program. The combined contract value exceeds €18 million, with €11 million tied to project and construction management support on the €2.5b convention center scheme and €7.5 million over five years for three stormwater initiatives...
ENXTAM:AALB
ENXTAM:AALBMachinery

Aalberts Reshapes Portfolio With BROEN Sale And €75m Buyback Plan

Aalberts has completed the divestment of BROEN A/S, advancing its ‘thrive 2030’ repositioning plan. The company is running a significant share buyback programme alongside the transaction. ENXTAM:AALB last closed at €32.78. For you as an ENXTAM:AALB watcher, these moves relate directly to how Aalberts is reshaping its portfolio and capital structure. The share price stands at €32.78, with a 14.9% gain year to date and a 3.5% return over 1 year, while 3 year and 5 year returns show declines...
ENXTAM:BFIT
ENXTAM:BFITHospitality

Basic Fit (ENXTAM:BFIT) Earnings Surge Tests Bullish High P/E Narrative

Basic-Fit (ENXTAM:BFIT) has wrapped up FY 2025 with second half revenue of €743.2 million and basic EPS of €0.34, alongside trailing 12 month revenue of €1.42 billion and basic EPS of €0.22. These figures frame the latest numbers in a broader earnings upswing. The company has seen revenue move from €630.44 million in the second half of 2024 to €743.2 million in the second half of 2025, while basic EPS shifted from €0.06 to €0.34 over the same periods. This sets up a story where higher sales...
ENXTAM:PHARM
ENXTAM:PHARMBiotechs

Pharming Group (ENXTAM:PHARM) Returns To Profitability Challenging Cautious Earnings Narratives

Pharming Group (ENXTAM:PHARM) has wrapped up FY 2025 with fourth quarter revenue of US$106.5 million and basic EPS of US$0.008, while trailing twelve month figures stand at US$376.1 million in revenue and basic EPS of US$0.004. This frames a year where profitability on a full year basis edges into positive territory. The company has seen quarterly revenue move from US$92.7 million in Q4 2024 and US$74.8 million in Q3 2024 to US$106.5 million in Q4 2025. Over the same period, quarterly basic...
ENXTAM:ENVI
ENXTAM:ENVIMachinery

Envipco Holding (ENXTAM:ENVI) Loss Of €10.8 Million Tests Bullish Profit Turnaround Narratives

Envipco Holding (ENXTAM:ENVI) has reported its FY 2025 results with fourth quarter revenue of €23.8 million and a basic EPS loss of €0.03, while trailing twelve month revenue stands at €90.4 million with a full year basic EPS loss of €0.18. Over recent quarters the company has seen revenue move between €21.0 million and €23.8 million per quarter, while quarterly basic EPS losses have ranged from €0.03 to €0.07. This sets the scene for a story where strong reported revenue growth meets...
ENXTAM:CVC
ENXTAM:CVCCapital Markets

CVC Capital Partners (ENXTAM:CVC) Margin Surge To 63.8% Tests Bullish Narratives

CVC Capital Partners (ENXTAM:CVC) has put up a punchy set of FY 2025 numbers, with first half revenue at €843.0 million and basic EPS of €0.54, set against trailing twelve month revenue of €1.85 billion and EPS of €1.11 that came with a very large year-on-year earnings increase and a net profit margin of 63.8% versus 14.4% the prior year. Over the past three reported halves, revenue has moved from €635.7 million with EPS of €0.05 in 1H 2024 to €926.2 million and EPS of €0.17 in 2H 2024,...
ENXTAM:ABN
ENXTAM:ABNBanks

ABN AMRO Bank (ENXTAM:ABN) Valuation Check After 2025 Annual Report On Growth And Capital Allocation

ABN AMRO Bank (ENXTAM:ABN) has released its 2025 Annual Report, giving investors fresh detail on value creation, capital allocation, cost efficiency, and sustainability commitments during a period of geopolitical and economic challenges. See our latest analysis for ABN AMRO Bank. At a share price of €28.25, ABN AMRO Bank has seen a 1-day share price return of 1.36% and a 7-day share price return of 1.07%. Its 30-day share price return of 10.26% and year to date share price return of 6.58%...